PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma

By Epistolato Maria  

The Women's Oncology Review, Vol. 5, Iss. 3, 2005-09 ,pp. : 149-150

Informa Healthcare

Access to resources Recommend Favorite

PIK3CA mutations in breast cancer are associated with poor outcome

By Li Shao   Rong Minna   Grieu Fabienne   Iacopetta Barry  

Breast Cancer Research and Treatment, Vol. 96, Iss. 1, 2006-03 ,pp. : 91-95

Springer Publishing Company

Access to resources Recommend Favorite

Mutations of the PIK3CA gene in ovarian and breast cancer

By Bellacosa Alfonso  

The Women's Oncology Review, Vol. 5, Iss. 4, 2005-12 ,pp. : 223-225

Informa Healthcare

Access to resources Recommend Favorite

Clinical usefulness of KRAS, BRAF, and PIK3CA mutations as predictive markers of cetuximab efficacy in irinotecan- and oxaliplatin-refractory Japanese patients with metastatic colorectal cancer

By Soeda Hiroshi   Shimodaira Hideki   Watanabe Mika   Suzuki Takao   Gamoh Makio   Mori Takahiro   Komine Keigo   Iwama Noriyuki   Kato Shunsuke   Ishioka Chikashi  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 670-677

Springer Publishing Company

Access to resources Recommend Favorite

PIK3CA Mutations and BRCA1 Expression in Breast Cancer: Potential Biomarkers for Chemoresistance

By Santarpia Mariacarmela   Altavilla Giuseppe   Margeli Mireia   Cirauqui Beatriz   Mesiti Mario   Cavallari Vittorio   Ramirez Jose Luis   Sanchez-Ronco Maria   Santarpia Libero   Taron Miquel   Rosell Rafael  

Cancer Investigation, Vol. 26, Iss. 10, 2008-12 ,pp. : 1044-1051

Informa Healthcare

Access to resources Recommend Favorite